PTC Therapeutics, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
-9.58 | 33.49 | -128.6% | -6.94 | +37.93% |
| P/S |
|
4.36 | 129.83 | -96.64% |
|
|
| P/BV |
|
-3.2 | 260.15 | -101.23% |
|
|
| P/FCF |
|
-30.47 | -180.12 | -83.08% |
|
|
| Ev/Ebitda |
|
-25.96 | -28.84 | -9.99% |
|
|
| Ev/S |
|
3.88 | 548.04 | -99.29% |
|
|
| Ev/FCF |
|
-27.38 | -289.87 | -90.55% |
|
|
| E/P |
|
-0.1044 | 0.0228 | -558.44% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-14.93 | -375.54 | -96.02% | -26.53 | -43.72% |
| ROE |
|
37.91 | 106.63 | -64.45% |
|
|
| ROA |
|
-20.18 | -2.32 | 771.6% |
|
|
| ROIC |
|
-73.6 | 0.8343 | -8922.06% |
|
|
| ROS |
|
-45.03 | -298.59 | -84.92% |
|
|
| ROCE |
|
17.86 | 3.17 | 462.97% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-3.23 | 0.9426 | -442.84% | -7.13 | -54.66% |
| Nеt Debt/Ebitda |
|
3.24 | 1.04 | 210.27% |
|
|
| Debt/Ratio |
|
0.2283 | 0.1798 | 27.01% |
|
|
| Debt/Equity |
|
-2.55 | 1.62 | -257.63% |
|
|
| Debt/Net Income |
|
-1.07 | -1.65 | -35.13% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5317 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.8182 | -100% | ||
| DSI |
|
0 | 0.2062 | -100% |
|
|
| Average dividend growth |
|
0 | 2.29 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.5169 | -100% |
|
|
| Average percentage for payments |
|
0 | 58.77 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5317 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
111.86 | -99.58 | -212.33% | ||
| Growth impulse Ebitda in 5 years |
|
-47.12 | -152.61 | -69.12% | ||
| Growth impulse Net Income in 5 years |
|
-17.09 | -115.25 | -85.17% | ||
| Growth impulse FCF in 5 years |
|
-54.32 | -161.2 | -66.3% | ||
| Growth impulse EPS in 5 years |
|
-28.8 | -106.31 | -72.91% |
IP Score
3.2/10
